AlloSource Honors Dr. David Argo With The Annual Dr. Steven Gitelis Inspiration Award
Centennial, Colo. — June 9, 2021 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, today announced it is awarding Dr. David Argo with its fifth annual Dr. Steven Gitelis Inspiration Award. The…
Study On The Biomechanical Properties of Dermal Matrices Published In Plastic And Reconstructive Surgery—Global Open Finds AlloSource’s Meshed AlloMend Has Superior Fluid Egress Properties
Centennial, Colo. — June 2, 2021 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, today announced Plastic and Reconstructive Surgery—Global Open published the findings of a study titled “The…
AlloSource Announces First Patients Implanted With AlloWrap Amniotic Membrane In Clinical Study For Two-Level Anterior Cervical Discectomy And Fusion Procedures
Centennial, Colo. — February 23, 2021 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products, today announced the first patients have been enrolled in its clinical study titled, A Randomized, Controlled Study to Evaluate Effectiveness of…
AlloSource’s ProChondrix CR, Cryopreserved Osteochondral Allograft, To Be Featured At The British Patellofemoral Society Meeting
Centennial, Colo. — November 15, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products, today announced its ProChondrix® CR allograft, will be featured in a presentation by Dr. David Argo at the British Patellofemoral Society…
AlloSource Commits Multi-Year Financial Support To Phoenix Society For Burn Survivors
The generous donation will support burn survivor healing through major initiatives surrounding patient and family care, virtual programming and peer support Centennial, Colo. — December 22, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and…
Science Behind AlloSource’s Cryopreserved Cartilage Published In Journal Of Orthopaedic Surgery And Research
Peer review describes the data behind ProChondrix CR’s ability to maintain the functional components of healthy cartilage after two years of cryopreserved storage Centennial, Colo. — December 8, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular…
AlloSource Receives Gold Level Recognition For Workplace Health Achievement From The American Heart Association Three Years In A Row
Centennial, Colo. — November 24, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, today announced it received Gold level recognition from the American Heart Association for continuing to…
AlloSource Announces First Patients Complete 12-Month Milestone In ProChondrix CR Clinical Study For Cartilage Defects In The Knee
Centennial, Colo. — November 17, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products, today announced its first patients have completed their 12-month follow-up in its five-year study titled, A Prospective, Multi-Center Study…
AlloSource Honors Dr. Ergun Kocak With The Annual Dr. Steven Gitelis Inspiration Award
Centennial, Colo. — August 4, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, today announced it is awarding Dr. Ergun Kocak with its fourth annual Dr. Steven Gitelis Inspiration Award.…
AlloSource Names Tendon and Ligament Portfolio Under New Brand AlloConnex
Centennial, Colo. — July 23, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts to help surgeons heal their patients, today announced it is naming its tendon and ligament portfolio under the new brand AlloConnex™. “Over the…
Research Shows ProChondrix CR Maintains Consistent, High Cell Viability For Two Years
Proprietary cryopreservation technique of thin, laser-etched osteochondral allografts provides longer shelf-life, expanding access for cartilage treatment Centennial, Colo. — October 7, 2019 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells…
AlloSource Celebrates 25 Years of Doing More With Life
Milestone highlights organization’s growth into one of the largest tissue banks in the U.S. Centennial, Colo. — August 9, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, will be celebrating 25 years of honoring donors…
AlloSource Partners in Manufacturing USA Institute
Collaboration with the Advanced Regenerative Manufacturing Institute’s membership deepens opportunities for growth in the regenerative medicine space Centennial, Colo. — June 18, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and…
AlloSource Awards Dr. Matthew Provencher The Annual Dr. Steven Gitelis Inspiration Award
Centennial, Colo. — May 8, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced it is awarding Dr. Matthew Provencher with its third annual Dr. Steven Gitelis Inspiration Award. The award honors a physician who…
AlloSource Hosts 25th Anniversary Event Featuring Columbine Survivor and Tissue Recipient Kacey Ruegsegger Johnson
Centennial, Colo. — April 25, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today celebrates 25 years of honoring donors and helping patients heal with an event featuring Columbine survivor and tissue recipient Kacey…
AlloSource Announces First Patient Enrolled in ProChondrix CR Cartilage Defect Study
Centennial, Colo. — March 20, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced it has enrolled the first patient in a study titled A Prospective, Multi-Center Study Evaluating ProChondrix® CR for the Repair…
March 20, 2019Press ReleasesProChondrix CR,Cartilage,patient,Study
AlloSource Announces Two-Year Shelf Life On ProChondrix CR Fresh Cryopreserved Osteochondral Allograft
Centennial, Colo. — March 12, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that ProChondrix® CR now has a two-year shelf life based on the results of real-time testing. ProChondrix CR helps deliver the…
March 12, 2019Press ReleasesAllograft,ProChondrix CR,Shelf Life
AlloSource Named One Of The 2019 Training Top 125 Organizations By Training Magazine
Centennial, Colo. — February 26, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced it was named one of the 2019 Training Top 125 by Training magazine for excellence in employer-sponsored training and…
February 26, 2019Press ReleasesAward,Top 125,Training Magazine
AlloSource Scientists Contribute to NASA’s Jet Propulsion Laboratory Study on Antimicrobial Survivability on the International Space Station
Centennial, Colo. — December 10, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, served as a contributing science team to NASA’s Jet Propulsion Laboratory’s (JPL) scientific study on further antimicrobial survivability on…
December 10, 2018Press ReleasesNASA,Enterobacter bugandesis,microbial
AlloSource Granted Patent for Proprietary Laser Cutting Enclosure
Centennial, Colo. — November 16, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, received U.S. patent 10,105,793, titled Enclosure for laser cutting of human tissue. This patent encompasses AlloSource’s method of producing…
November 16, 2018Press ReleasesAllograft,ProChondrix,Patent,osteochondral allograft
AlloSource Announces Two Presentations at the North American Spine Society Annual Meeting
Centennial, Colo. — September 25, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced two presentations on the use of biologics in spinal fusion surgery at AlloSource’s booth #2031 at the North American Spine…
September 25, 2018Press ReleasesAlloSource,AlloFuse,Surgeon,Spine
AlloSource Named One of the 100 Healthiest Workplaces in America by Healthiest Employers
Centennial, Colo. — September 21, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that Healthiest Employers® named AlloSource one of the 100 Healthiest Workplaces in America. Over 1,000 organizations across…
September 21, 2018Press ReleasesAlloSource,Award,Wellness Program,Benefits,Employees
AlloSource Receives Gold Level Recognition for Workplace Health From the American Heart Association
Centennial, Colo. — August 9, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced it received Gold level recognition from the American Heart Association for promoting a workplace culture of health and…
August 9, 2018Press ReleasesWellness Program,Benefits,Employees
AlloSource Awards Dr. Kevin Shea the Annual Dr. Steven Gitelis Inspiration Award
Centennial, Colo. — July 17, 2018 — AlloSource, one of the largest nonprofit cellular and tissue networks in the country, offering life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility, today announced that it will award…
July 17, 2018Press ReleasesAlloSource,Allografts,Orthopedics,Surgeon